Columbia Laboratories Inc. said Wednesday that it has reachedan agreement to share technology with Insite Vision Inc.

Columbia (AMEX:COB) of Hollywood, Fla., obtained exclusiveworldwide rights to market veterinary ophthalmic productsusing Insite's sustained-release gel technology. Columbia alsoobtained the right to market in all parts of the world exceptNorth America and parts of Asia ophthalmic over-the-counterdrugs using Insite's technology.

In exchange, Alameda, Calif.-based Insite obtained exclusiveworldwide rights to market prescription ophthalmic productsusing Columbia's bioadhesive technology. In addition, privatelyheld Insite obtained the right to market in North America andportions of Asia ophthalmic over-the-counter drugsincorporating Columbia's technology.

The deal doesn't include any cash or royalties, said HelenWitters, Columbia vice president. -- KB

(c) 1997 American Health Consultants. All rights reserved.